Melanie Solomon | Investor Relations |
Ming Hsieh | Chief Executive Officer |
Brandon Perthuis | Chief Commercial Officer |
Paul Kim | Chief Financial Officer |
Tyler Anderson | Piper Sandler |
Hello, and welcome to the Fulgent Genetics Q4 and Fiscal Year 2022 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Melanie Solomon, Investor Relations. Please go ahead.